Angioleiomyoma is a benign mesenchymal soft tissue tumor originating from vascular smooth muscle. Angioleiomyoma is rarely encountered in the oral cavity, as smooth muscle is primarily found in the tunica media of blood vessels and with the most commonly affected sites being the lips (48.6%), tongue (9.2%), hard palate (9.2%) and buccal mucosa (9.2%) [
4]. This tumor typically presents as a slow-growing, painless, and well-circumscribed mass [
2]. However, some cases report associated pain, which may be due to nerve involvement or vascular compression [
5].
MRI characteristics of oral angioleiomyomas are not well-documented due to their rarity, but as seen in this case, they typically present as well-defined masses with heterogeneous signal intensity patterns [
3]. Recent studies highlight the importance of MRI in preoperative assessment, MRI features such as hyperintensity on T2-weighted imaging with hypointense rim corresponding to a fibrous capsule, isointense to slightly hyperintense compared to muscle on T1-weighted images and uniform enhancement on post-contrast images [
6]. It is crucial to differentiate angioleiomyomas from other benign tumors that can develop in the palate (e.g. neurilemmomas, neurofibroma, pleomorphic adenoma) using MRI for accurate diagnosis and treatment planning in advance to the surgical intervention. Neurilemmomas have a very distinctive appearance with a target sign on peripheral nerves in MRI. Neurofibroma tend to show low-to-intermediate signal intensity on T1-weighted images and a heterogeneous appearances on T2-weighted images [
7]. These imaging characteristics enable clinicians to exclude neurofibromas and neurilemmomas from the differential diagnosis. Pleomorphic adenomas present with imaging findings similar to angioleiomyomas, including a predilection for homogeneous intermediate signal intensity on T1-weighted images and heterogeneous high signal intensity on T2-weighted images [
8]. Advanced imaging modalities such as CT scans and doppler ultrasonography may help in assessing the lesion’s vascular nature and detecting blood flow patterns within the tumor. However, due to overlapping features with other mesenchymal neoplasms, histopathological confirmation remains the gold standard. Histopathologically, angioleiomyomas is classified into three subtypes: solid, venous and cavernous. The solid-type consists of compacted bundles of smooth muscle cells and thinwalled blood vessels, while the venous-type exhibits thick-walled vascular channels that blend with smooth muscle bundles. The cavernous-type, in contrast, is characterized by large vascular channels with thin muscular walls [
9]. The differential diagnosis of angioleiomyoma in the oral cavity is crucial due to its resemblance to other soft tissue neoplasm, including pyogenic granuloma, peripheral giant cell granuloma, peripheral ossifying fibroma, schwannoma, and minor salivary gland tumors [
5]. Immunohistochemical analysis is essential for differential diagnosis, as angioleiomyomas stain positively for SMA, Desmin, and Caldesmon while lacking markers for epithelial, neural, and endothelial cells [
10]. In this case, immunohistochemical staining for SMA, Desmin, Caldesmon, S100, CD31, CD34 and HMB45 were performed. SMA serves as the key immunomarker of smooth muscle cells, Desmin staining identifies a specific intermediate filament protein in muscle cell and Caldesmon, an actinbinding protein, regulates contraction in smooth muscle cells. Our case was confirmed as a muscle tumor, differentiated from other spindle cell tumors based on tests using these markers. Unlike these findings, all the other markers showed negative results. Negativity for S100 helps exclude the possibility of neural tumors such as schwannomas and neurofibromas, because this marker is expressed in schwann cells, melanocytes, and certain dendritic cells. in addition, vascular tumors such as hemangiomas and angiosarcomas were excluded from the final diagnosis due to negative immunohistochemical sensitivity to CD31, CD34 which are specific markers expressed in vascular endothelial cells. these tumor cells were also negative for HMB45 staining, the melanocytic differentiation marker, leading to exclusion of melanocytic tumors including spindle cell melanoma [
11].